Global X Aging Population ETF AGNG
40.59 USD +0.86 (+2.15%)
Nov 4, 2026, 10:17 AM EST
40.59 Day range 40.84
33.66 52-week range 40.84
- YTD
- +13.05%
- 1 year
- +20.11%
- Market cap
- 96.38M
- EPS (ttm)
- 1.48
- P/E ratio
- 27.34
- YTD return
- +13.05%
- 1-year return
- +20.11%
- Volume
- 983
- Avg volume
- 10.75K
- Open
- 40.84
- Previous close
- 39.73
- Day's range
- 40.59 – 40.84
- 52-week range
- 33.66 – 40.84
2Y +8.57 (+26.57%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 31.68
- 200-day average
- 30.99
About Global X Aging Population ETF
The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
News
Bet on These Healthcare ETFs to Benefit From the Aging US Population Global X Aging Population ETF (NASDAQ:AGNG) Shares Shorted: Short Interest Down 48.7% in September
3 Longevity ETFs to Buy and Hold (and Hold)
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics
Global X Aging Population ETF (NASDAQ:AGNG) Short Interest Update
Global X Aging Population ETF (NASDAQ:AGNG) Short Interest Down 73.1% in December
I’m 50 years old with $1 million in cash. What’s the ideal portfolio to retire by 60?
The 3 Hottest Healthcare ETFs to Buy in 2024
Disruptive Tech Theme of the Week: Weight Loss Revolution Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups
Your note
Sign in to keep a note on AGNG — it syncs with the Stock Master app.
